Utility of apoB/apoA1 ratio for the prediction of cardiovascular risk in childrenwith metabolic syndrome

Indian Journal of Pediatrics

Volumn 77, Issue 11, 2010, Pages 1261-1265

  Erdeve, Senay Savas ^a   Simsek, Enver ^b   Dallar, Yildiz ^c   Biyikli, Zeynep ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b Osmangazi University School of Medicine   (Turkey)

^c Department of Pediatrics Ankara Research and Training Hospital ^*  (Turkey)

Author keywords

Apolipoprotein AI; Apolipoprotein B; Apolipoprotein B apolipoprotein AI ratio; Child; Metabolic syndrome

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; CARDIOVASCULAR RISK; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREDICTION; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CARDIOVASCULAR DISEASES; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; OBESITY; RISK ASSESSMENT; TURKEY;

EID: 78651079797     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-010-0217-8     Document Type: Article

References (18)

1. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diab Care. 2001;24:683-9.
2. Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver dam. Diab Care. 2002;25:1790-4.
3. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49:403-14.
4. Walldius G, Jungner I. The apoB/apoA-I ratio: A strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy-a review of the evidence. J Intern Med. 2006;259:493-519.
5. Bachorik PS, Lovejoy KL, Carroll MD, Johnson CL. Apolipoprotein B and AI distribution in the United States, 1988-1991: Results of the National Health and Nutrition Examination Survey III (NHANES III). Clin Chem. 1997;43:2364-78.
6. Bachorik PS, Kwiterovich PO. The measurement of plasma cholesterol, low density lipoprotein- and high density lipoprotein cholesterol. In: Hommes FA, editor. Techniques in diagnostic human biochemical genetics: A laboratory manual. New York: Wiley-Liss, Inc.; 1991. p. 425-9.
7. Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F. The Apolipoprotein b/apolipoprotein AI ratio in the metabolic syndrome-should we start using it? J Cardiometab Syndr. 2008;3 (1):53-4.
8. Sierra-Johnson J, Somers VK, Kuniyoshi H, et al. Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome. Am J Cardiol. 2006;98 (10):1369-73.
9. Troiano RP, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL. Overweight prevalence and trends for children and adolescents. The National Health and Nutrition Examination Surveys, 1963 to 1991. Arch Pediatr Adolesc Med. 1995;149:1085-91.
10. Tumer N, Yalçinkaya F, Ince E, et al. Blood pressure normograms for children and adolescents in Turkey. Pediatr Nephrol. 1999;13:438-43.
11. American Diabetes Association. Standards of medical care in diabetes. Diab Care. 2007;30:S4-S41.
12. National Cholesterol Education Program (NCEP): Highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992;89:495-501.
13. Hatipoglu N, Ozturk A, Mazicioglu MM, Kurtoglu S, Seyhan S, Lokoglu F. Waist circumference percentiles for 7- to 17-year-old Turkish children and adolescents. Eur J Pediatr. 2007;167:383-9.
14. Zonderland ML, Erich WB, Erkelens DW, et al. Plasma lipids and apoproteins, body fat distribution and body fatness in early pubertal children. Int J Obes. 1990;14:1039-46.
15. Zwiaueer KFM, Pakosta R, Mueller T, Widhalm K. Cardiovascular risk factors in obese children in relation to weight and body fat distribution. J Am Coll Nutr. 1992;11:41S-50S.
16. Wallenfeldt K, Bokemark L, Wikstrand J, Hulthe J, Fageberg B. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intimamedia thickness during 3 years in middle-aged men. Stroke. 2004;35:2248-52.
17. Retnakaran R, Zinman B, Connelly PW, Haris SB, Hanley AJ. Nontraditional cardiovascular risk factors in pediatric metabolic syndrome. J Pediatr. 2006;148:176-82.
18. Bueno G, Bueno O, Moreno LA, et al. Diversity of metabolic syndrome risk factors in obese children and adolescents. J Physiol Biochem. 2006;62:125-33.